US 11,987,573 B2
Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors
Abdul Quddus, Nottingham (GB); and Emma Blackham, Nottingham (GB)
Assigned to Step Pharma S.A.S., Paris (FR)
Appl. No. 17/287,137
Filed by Step Pharma S.A.S., Paris (FR)
PCT Filed Oct. 23, 2019, PCT No. PCT/EP2019/078848
§ 371(c)(1), (2) Date Apr. 21, 2021,
PCT Pub. No. WO2020/083975, PCT Pub. Date Apr. 30, 2020.
Claims priority of application No. 18202136 (EP), filed on Oct. 23, 2018; application No. PCT/EP2018/086617 (WO), filed on Dec. 21, 2018; and application No. PCT/EP2019/057320 (WO), filed on Mar. 22, 2019.
Prior Publication US 2021/0387965 A1, Dec. 16, 2021
Int. Cl. C07D 401/14 (2006.01); A61P 35/00 (2006.01); C07D 405/14 (2006.01)
CPC C07D 401/14 (2013.01) [A61P 35/00 (2018.01); C07D 405/14 (2013.01)] 5 Claims
 
1. A compound which is 4-(2-(cyclopropanesulfonamido)pyrimidin-4-yl)-N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)tetrahydro-2H-pyran-4-carboxamide:

OG Complex Work Unit Chemistry
or a salt and/or solvate thereof.